Case number 2021-1360
Teva Pharmaceuticals USA v. Corcept Therapeutics, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 13, 2022 | 36 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [824321] [MVH] [Entered: 01/13/2022 09:16 AM] (2) |
| Dec 23, 2021 | 0 | TEVA PHARMACEUTICALS USA v. CORCEPT THERAPEUTICS, INC. [OPINION] [precedential] (0) |
| Dec 7, 2021 | 35 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [816701] [MVH] [Entered: 12/07/2021 09:51 AM] (1) |
| Dec 7, 2021 | 34 | OPINION filed for the court by Moore, Chief Judge; Newman, Circuit Judge and Reyna, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [816699] [MVH] [Entered: 12/07/2021 09:50 AM] (10) |
| Oct 5, 2021 | 33 | Submitted after ORAL ARGUMENT to Panel: Moore, Chief Judge; Newman, Circuit Judge and Reyna, Circuit Judge.Arguing counsel: John Christopher Rozendaal for Teva Pharmaceuticals USA, Inc. and Mr. Eric C. Stops for Corcept Therapeutics, Inc.Oral Argument Audio available here. [803786] [JCP] [Entered: 10/05/2021 04:48 PM] (0) |
| Oct 1, 2021 | 32 | 6 paper copies of Doc. No. [30] received from Appellant Teva Pharmaceuticals USA, Inc.. [803490] [VDW] [Entered: 10/04/2021 04:32 PM] (0) |
| Sep 30, 2021 | 31 | Outstanding paper copies the corrected joint appendix must be submitted before close of business on 10/4/21. See Fed. Cir. R. 25(c)(3)(A). [802951] [MVH] [Entered: 09/30/2021 04:57 PM] (0) |
| Sep 29, 2021 | 30 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellant Teva Pharmaceuticals USA, Inc. Service: 09/29/2021 by email. [802723]--[Edited 09/30/2021 by MVH - Reason: to revise docket text] [John Rozendaal] [Entered: 09/29/2021 10:52 PM] (940) |
| Sep 29, 2021 | 29 | Notice of Correction to Doc No. [17] for Appellant Teva Pharmaceuticals USA, Inc.. Service: 09/29/2021 by email. [802722] [21-1360] [John Rozendaal] [Entered: 09/29/2021 10:44 PM] (3) |
| Sep 15, 2021 | 28 | Response to notice of oral argument from Appellant Teva Pharmaceuticals USA, Inc.. Service: 09/15/2021 by email. [799639] [21-1360] [John Rozendaal] [Entered: 09/15/2021 02:01 PM] (3) |
| Sep 15, 2021 | 27 | Response to notice of oral argument from Appellee Corcept Therapeutics, Inc.. Service: 09/15/2021 by email. [799561] [21-1360] [Eric Stops] [Entered: 09/15/2021 12:20 PM] (3) |
| Aug 20, 2021 | 26 | NOTICE OF ORAL ARGUMENT. Panel: 2110E. Case scheduled October 5, 2021. Response to Notice of Oral Argument due: 09/15/2021. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [794460] [MVH] [Entered: 08/20/2021 04:41 PM] (2) |
| Jul 15, 2021 | 25 | The following conflict dates submitted by Eric C. Stops for Corcept Therapeutics, Inc. have been accepted by the court: 10/06/2021, 10/07/2021, 10/08/2021, 11/04/2021. [786348] [MJL] [Entered: 07/15/2021 09:02 AM] (0) |
| Jul 15, 2021 | 24 | The following conflict dates submitted by John Christopher Rozendaal for Teva Pharmaceuticals USA, Inc. have been accepted by the court: 09/02/2021, 09/03/2021, 01/10/2022, 01/11/2022, 01/12/2022. [786347] [MJL] [Entered: 07/15/2021 09:01 AM] (0) |
| Jul 14, 2021 | 23 | Notice from Appellee Corcept Therapeutics, Inc. regarding conflicts with oral argument. Service: 07/14/2021 by email. [786210] [21-1360] [Eric Stops] [Entered: 07/14/2021 01:59 PM] (3) |
| Jul 14, 2021 | 22 | Notice from Appellant Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument. Service: 07/14/2021 by email. [786204] [21-1360] [John Rozendaal] [Entered: 07/14/2021 01:41 PM] (2) |
| Jul 9, 2021 | 20 | 6 paper copies of Doc. No. [13] received from Appellee Corcept Therapeutics, Inc.. [785857] [VDW] [Entered: 07/13/2021 11:55 AM] (0) |
| Jul 8, 2021 | 21 | 6 paper copies of Doc. No. [17], [16], [9] received from Appellant Teva Pharmaceuticals USA, Inc.. [785965] [VDW] [Entered: 07/13/2021 04:10 PM] (0) |
| Jul 7, 2021 | 18 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [784633] [EKD] [Entered: 07/07/2021 04:32 PM] (0) |
| Jul 7, 2021 | 19 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [784634] [EKD] [Entered: 07/07/2021 04:32 PM] (1) |
| Jul 2, 2021 | 17 | MODIFIED ENTRY: APPENDIX FILED by Appellant Teva Pharmaceuticals USA, Inc. Service: 07/02/2021 by email. [784129] --[Edited 07/07/2021 by EKD - compliance review complete]. This document has been corrected. See Doc. No. [30] [John Rozendaal] [Entered: 07/02/2021 05:13 PM] (940) |
| Jun 25, 2021 | 16 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Teva Pharmaceuticals USA, Inc. Service: 06/25/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [782699] --[Edited 06/25/2021 by EKD - compliance review complete] [John Rozendaal] [Entered: 06/25/2021 01:23 PM] (34) |
| Jun 4, 2021 | 15 | **TEXT ONLY** ORDER granting motion to extend time to file brief [14] filed by Appellant Teva Pharmaceuticals USA, Inc. The reply brief is due 06/25/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [778449] [EKD] [Entered: 06/04/2021 08:22 AM] (0) |
| Jun 3, 2021 | 14 | MOTION of Appellant Teva Pharmaceuticals USA, Inc. to extend the time to 06/25/2021 to file brief. Service: 06/03/2021 by email. [778411] [21-1360] [John Rozendaal] [Entered: 06/03/2021 04:28 PM] (8) |
| May 21, 2021 | 13 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Corcept Therapeutics, Inc. Service: 05/21/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [776524] --[Edited 05/24/2021 by EKD - compliance review complete] [Eric Stops] [Entered: 05/21/2021 04:06 PM] (69) |
| Apr 2, 2021 | 12 | **TEXT ONLY** ORDER granting motion to extend time to file brief [11] filed by Appellee Corcept Therapeutics, Inc. The response brief is due 05/21/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [766370] [EKD] [Entered: 04/02/2021 08:34 AM] (0) |
| Apr 1, 2021 | 11 | MOTION of Appellee Corcept Therapeutics, Inc. to extend the time to 05/21/2021 to file brief. Service: 04/01/2021 by email. [766360] [21-1360] [Eric Stops] [Entered: 04/01/2021 08:48 PM] (0) |
| Apr 1, 2021 | 10 | Amended Certificate of Interest for Appellee Corcept Therapeutics, Inc.. Service: 04/01/2021 by email. [766322] [21-1360] [Eric Stops] [Entered: 04/01/2021 04:55 PM] (0) |
| Mar 12, 2021 | 9 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Teva Pharmaceuticals USA, Inc. Service: 03/12/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [762034] --[Edited 03/15/2021 by EKD - compliance review complete] [John Rozendaal] [Entered: 03/12/2021 04:57 PM] (0) |
| Jan 11, 2021 | 8 | Certified list received. Service: 01/11/2021 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [748471] [EKD] [Entered: 01/11/2021 03:34 PM] (0) |
| Dec 16, 2020 | 2 | Entry of appearance for John Christopher Rozendaal; Deborah Ann Sterling; Uma N. Everett; Olga A. Partington; William H. Milliken as counsel for Appellant Teva Pharmaceuticals USA, Inc.. Service: 12/16/2020 by email. [743289] [21-1360] [John Rozendaal] [Entered: 12/16/2020 04:17 PM] (2) |
| Dec 16, 2020 | 7 | Docketing Statement for the Appellee Corcept Therapeutics, Inc.. Service: 12/16/2020 by email. [743335] [21-1360] [Daniel Wiesner] [Entered: 12/16/2020 05:40 PM] (0) |
| Dec 16, 2020 | 6 | Certificate of Interest for Appellee Corcept Therapeutics, Inc.. Service: 12/16/2020 by email. [743333] [21-1360] [Daniel Wiesner] [Entered: 12/16/2020 05:34 PM] (0) |
| Dec 16, 2020 | 5 | Entry of appearance for F. Dominic Cerrito; Eric C. Stops; William B. Adams; Frank C. Calvosa; Daniel C. Wiesner as counsel for Appellee Corcept Therapeutics, Inc.. Service: 12/16/2020 by email. [743332] [21-1360] [Daniel Wiesner] [Entered: 12/16/2020 05:30 PM] (0) |
| Dec 16, 2020 | 4 | Docketing Statement for the Appellant Teva Pharmaceuticals USA, Inc.. Service: 12/16/2020 by email. [743296] [21-1360] [John Rozendaal] [Entered: 12/16/2020 04:22 PM] (0) |
| Dec 16, 2020 | 3 | Certificate of Interest for Appellant Teva Pharmaceuticals USA, Inc.. Service: 12/16/2020 by email. [743291] [21-1360] [John Rozendaal] [Entered: 12/16/2020 04:20 PM] (0) |
| Dec 2, 2020 | 1 | Appeal docketed. Received: 11/24/2020. [739682] Entry of Appearance is due on 12/16/2020. Certificate of Interest is due on 12/16/2020. Docketing Statement is due on 12/16/2020. Certified List is due on 01/11/2021. [EKD] [Entered: 12/02/2020 02:23 PM] (68) |
